Arete Wealth Advisors, LLC Biocryst Pharmaceuticals Inc Transaction History
Arete Wealth Advisors, LLC
- $1.31 Billion
- Q1 2025
A detailed history of Arete Wealth Advisors, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Arete Wealth Advisors, LLC holds 20,200 shares of BCRX stock, worth $168,670. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,200
Previous 20,200
-0.0%
Holding current value
$168,670
Previous $152,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding BCRX
# of Institutions
302Shares Held
180MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA20.5MShares$172 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$167 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$74.6 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$72.6 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$65.2 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.55B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...